17-78134866-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152468.5(TMC8):​c.988-4G>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0756 in 1,613,664 control chromosomes in the GnomAD database, including 5,020 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.084 ( 553 hom., cov: 32)
Exomes 𝑓: 0.075 ( 4467 hom. )

Consequence

TMC8
NM_152468.5 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00003550
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.18
Variant links:
Genes affected
TMC8 (HGNC:20474): (transmembrane channel like 8) Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 8 predicted transmembrane domains and 3 leucine zipper motifs. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 17-78134866-G-T is Benign according to our data. Variant chr17-78134866-G-T is described in ClinVar as [Benign]. Clinvar id is 1098860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78134866-G-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0854 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TMC8NM_152468.5 linkuse as main transcriptc.988-4G>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000318430.10 NP_689681.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TMC8ENST00000318430.10 linkuse as main transcriptc.988-4G>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_152468.5 ENSP00000325561 P2Q8IU68-1

Frequencies

GnomAD3 genomes
AF:
0.0837
AC:
12722
AN:
152044
Hom.:
553
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0878
Gnomad AMI
AF:
0.159
Gnomad AMR
AF:
0.0634
Gnomad ASJ
AF:
0.142
Gnomad EAS
AF:
0.0909
Gnomad SAS
AF:
0.0667
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.0790
Gnomad OTH
AF:
0.0987
GnomAD3 exomes
AF:
0.0785
AC:
19674
AN:
250726
Hom.:
872
AF XY:
0.0796
AC XY:
10807
AN XY:
135684
show subpopulations
Gnomad AFR exome
AF:
0.0880
Gnomad AMR exome
AF:
0.0472
Gnomad ASJ exome
AF:
0.143
Gnomad EAS exome
AF:
0.0960
Gnomad SAS exome
AF:
0.0589
Gnomad FIN exome
AF:
0.0896
Gnomad NFE exome
AF:
0.0807
Gnomad OTH exome
AF:
0.0882
GnomAD4 exome
AF:
0.0747
AC:
109225
AN:
1461502
Hom.:
4467
Cov.:
34
AF XY:
0.0754
AC XY:
54854
AN XY:
727048
show subpopulations
Gnomad4 AFR exome
AF:
0.0916
Gnomad4 AMR exome
AF:
0.0497
Gnomad4 ASJ exome
AF:
0.144
Gnomad4 EAS exome
AF:
0.0829
Gnomad4 SAS exome
AF:
0.0623
Gnomad4 FIN exome
AF:
0.0911
Gnomad4 NFE exome
AF:
0.0729
Gnomad4 OTH exome
AF:
0.0809
GnomAD4 genome
AF:
0.0837
AC:
12736
AN:
152162
Hom.:
553
Cov.:
32
AF XY:
0.0841
AC XY:
6258
AN XY:
74412
show subpopulations
Gnomad4 AFR
AF:
0.0878
Gnomad4 AMR
AF:
0.0632
Gnomad4 ASJ
AF:
0.142
Gnomad4 EAS
AF:
0.0907
Gnomad4 SAS
AF:
0.0667
Gnomad4 FIN
AF:
0.101
Gnomad4 NFE
AF:
0.0790
Gnomad4 OTH
AF:
0.103
Alfa
AF:
0.0666
Hom.:
167
Bravo
AF:
0.0829
Asia WGS
AF:
0.0780
AC:
269
AN:
3478
EpiCase
AF:
0.0920
EpiControl
AF:
0.0872

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJul 09, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Epidermodysplasia verruciformis, susceptibility to, 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMay 18, 2021- -
Epidermodysplasia verruciformis Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.28
DANN
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000036
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.25
Position offset: 28

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs62079073; hg19: chr17-76130947; COSMIC: COSV59211421; COSMIC: COSV59211421; API